Stocks and Investing
Stocks and Investing
Fri, December 1, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Arun Viswanathan Upgraded (CC) to Buy and Increased Target to $40 on, Dec 1st, 2023
Arun Viswanathan of RBC Capital, Upgraded "The Chemours Company" (CC) to Buy and Increased Target from $28 to $40 on, Dec 1st, 2023.
Arun has made no other calls on CC in the last 4 months.
There are 5 other peers that have a rating on CC. Out of the 5 peers that are also analyzing CC, 4 agree with Arun's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jeffrey Zekauskas of "JP Morgan" Maintained at Hold with Decreased Target to $26 on, Tuesday, November 7th, 2023
- Duffy Fischer of "Goldman Sachs" Maintained at Hold with Decreased Target to $30 on, Tuesday, October 31st, 2023
- Michael Leithead of "Barclays" Maintained at Hold with Decreased Target to $28 on, Monday, October 30th, 2023
- Vincent Andrews of "Morgan Stanley" Maintained at Hold with Decreased Target to $28 on, Monday, October 30th, 2023
This is the rating of the analyst that currently disagrees with Arun
- John McNulty of "BMO Capital" Maintained at Buy with Decreased Target to $39 on, Monday, October 30th, 2023
Contributing Sources